Eesti - eesti - Ravimiamet

berlin-chemie ag - ibuprofeen - suukaudne suspensioon - 40mg 1ml 150ml 1tk; 40mg 1ml 30ml 1tk; 40mg 1ml 200ml 1tk; 40mg 1ml 100ml 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - rivaroksabaan - õhukese polümeerikattega tablett - 15mg 14tk; 15mg 28tk; 15mg 100tk; 15mg 20tk; 15mg 42tk; 15mg 50tk; 15mg 30tk

Eesti - eesti - Ravimiamet

pfizer europe ma eeig - somatropiin - süstelahuse pulber ja lahusti - 12mg 1tk; 12mg 5tk

Eesti - eesti - Ravimiamet

pfizer europe ma eeig - somatropiin - süstelahuse pulber ja lahusti - 5,3mg 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - rivaroksabaan - õhukese polümeerikattega tablett - 20mg 28tk; 20mg 14tk; 20mg 98tk; 20mg 100tk; 20mg 5tk; 20mg 20tk; 20mg 30tk; 20mg 42tk; 20mg 50tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - rivaroksabaan - õhukese polümeerikattega tablett - 15mg 28tk; 15mg 98tk; 15mg 30tk; 15mg 90tk; 15mg 14tk; 15mg 60tk; 15mg 42tk; 15mg 100tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - rivaroksabaan - õhukese polümeerikattega tablett - 20mg 56tk; 20mg 42tk; 20mg 15tk; 20mg 28tk; 20mg 98tk; 20mg 30tk; 20mg 60tk; 20mg 90tk; 20mg 10tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - rivaroksabaan - õhukese polümeerikattega tablett - 2,5mg 28tk; 2,5mg 98tk; 2,5mg 56tk; 2,5mg 100tk; 2,5mg 14tk; 2,5mg 10tk; 2,5mg 30tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - rivaroksabaan - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - antitrombootilised ained - täiskasvanud patsientidel, kellele tehti plaaniline puusa- või põlveliigese asendamise operatsiooni venoosse trombemboolia (vte) ennetamine. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 haemodynamically ebastabiilne pe patsientidel). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 ja 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. ravi süvaveenide tromboos (dvt) ja kopsuarteri emboolia (pe), ning ennetamine korduvate digi-tv ja pe täiskasvanutel. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - rivaroksabaan - õhukese polümeerikattega tablett - 2,5mg 10tk; 2,5mg 60tk; 2,5mg 20tk; 2,5mg 100tk; 2,5mg 196tk; 2,5mg 168tk; 2,5mg 98tk